A 360° View of the News.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
NATO
Social Media
New York State Politics
Donald Trump
European Union
Heatwaves
Infrastructure
Natural Disasters
Amazon
Stock Markets
Work
Published • loading... • Updated

Upadacitinib Effective for Disease Clearance, Itch in Older Adults with Atopic Dermatitis

Summary by hcplive.com
These data from RAD 2025 highlight upadacitinib’s efficacy in the phase 3 Measure Up 1 and 2 studies for older adults with atopic dermatitis.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
contemporarypediatrics.comcontemporarypediatrics.com

FDA extends review of ruxolitinib cream for pediatric atopic dermatitis

The FDA has extended the review of ruxolitinib for atopic dermatitis in children 2 to 11 years to September 2025 to evaluate new CMC data.

Read Full Article
hcplive.comhcplive.com

Upadacitinib Effective for Disease Clearance, Itch in Older Adults with Atopic Dermatitis

These data from RAD 2025 highlight upadacitinib’s efficacy in the phase 3 Measure Up 1 and 2 studies for older adults with atopic dermatitis.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hcplive.com broke the news in on Friday, June 20, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States icon

United States

News
For You
SearchBlindspotLocal